+ All Categories
Home > Documents > ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ......

ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ......

Date post: 09-Oct-2020
Category:
Upload: others
View: 0 times
Download: 0 times
Share this document with a friend
37
ETHICS IN THE ERA OF SUPERBUGS… Nicolette du Plessis Paediatric Infectious Diseases [email protected] UPdate 2016 & antimicrobial resistance
Transcript
Page 1: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics

ETHICS IN THE ERA OF SUPERBUGS…

Nicolette du Plessis

Paediatric Infectious Diseases

[email protected]

UPdate 2016

& antimicrobial resistance

Page 2: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics
Page 3: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics
Page 4: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics
Page 5: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics
Page 7: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics
Page 8: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics
Page 9: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics

CDC: AMR to the US economy annually*

$20 billion in direct health care

$35 billion in lost productivity

UK government: death toll of AMR

300 million people 2050

financial loss $100 trillion**

*Centers for Disease Control and Prevention, 2013

** O’Neill, 2014

Page 10: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics

Life in the post-antibiotic era is going to suck…

Greatest single jump in average human lifespan

in the recorded history of medicine…

BUT after 80 years

antibiotic over-use

regulatory hostility

corporate indifference

Page 11: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics

“Post-antibiotic era”

Reality: minor scrapes and sore throats will

become life-threatening events

Page 12: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics
Page 13: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics

Drugs will eventually fail

Drugs are not magic bullets

Just stop-gap measures

Page 14: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics

….the industry’s obligation to be ethical…

…promises of specific benefits to consumers…

When you promise or claim that using an

antimicrobial product will protect health, are

there issues of right and wrong?

There certainly are…

Herman s. Ethics and personal care. Chemical reaction, GCI August 2009

Page 15: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics

Belmont report

Ethical principles:

1. Autonomy / Respect for persons

2. Beneficence

3. Justice

4. Non-maleficence…

Page 16: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics

APUA

The Alliance for the Prudent Use of Antibiotics

Dedicated to antimicrobial stewardship (AMS)

What ethical considerations are there in AMS?

The APUA Clinical Newsletter

Page 17: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics

Is a life in the future

worth less than a

life in the present?

J Antimicrob Chemother 2012

Page 18: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics

How do we fairly

allocate resources?

Page 19: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics

Ethical considerations in treating disease

Many current health strategies: saving a life now is more important than saving a life in the future

WHO Global Burden of Disease project discounted the value of future lives

Are we really making decisions that benefit the most people irrespective of when they live?

Healthcare resources should be used to maximises the health benefit for the largest number of people…

Wharam and Lazarou Parasites & Vectors 2013, 6:234

Page 20: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics

We cannot predict

state of future populations

unforeseen events (war or emerging diseases)

may make investments in the future worthless

Page 21: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics

Invest most of our resources now to eradicate

diseases, and therefore save countless future lives.

Page 22: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics

Even if attempts at eradication fails…

…can lead to large populations being relieved of

their burden of disease if only temporarily…

Page 23: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics

Multi-pronged strategy

Vaccine development

Improved diagnostics

Antibiotic resistance surveillance

Antimicrobial stewardship

APUA Clinical Newsletter Vol.30 No.1

Page 24: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics

Half of the world’s production of antibiotics

are still used in animal and fish farming, which

has created reservoirs for resistant bacteria and

exacerbates the problem further

Page 25: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics
Page 26: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics

How do we fairly allocate resources?

solidarity

liberty

privacy

reciprocity

fairness

the common good

Page 27: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics

AMR and Questions of Justice The global burden of infectious disease is distributed highly unevenly

low-income countries are disproportionately affected by AMR

high income countries bear a larger share of the response

Developing new drugs and technologies

Enhancing surveillance and reporting systems

Conducting research in areas not aligned with current national priorities

At the same time, a response to AMR will also require that we provide better

access to high-quality drugs, diagnostic tools and expert care.

Page 28: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics

Goldman, 2012; Rex, 2014; Drive, 2014

Page 29: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics

Some solutions…

…implementation of antibiotic stewardship in health care

facilities and the community; development of rapid,

point-of-care diagnostics; recruitment of academic and

industry partners to increase the pipeline of antibiotics,

vaccines, and alternative approaches; and international

collaboration for prevention, surveillance, and control of

antibiotic resistance.

Nathan and Cars, N Engl J Med 2014

Page 30: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics
Page 31: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics

Central ethical message here…

Distributive justice

Access: vulnerable populations are essential

Key interventions

Partnerships (Bills & Melinda Gates…)

Preventative measures (Vaccines…)

Rewards

Prioritization of medical use

Littmann J. The Ethical Significance of Antimicrobial Resistance. Public Health Ethics 2015;1–16.

Page 32: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics

Respect for persons

Protecting the autonomy of all people

Treating them with courtesy and respect

Allowing for informed consent

New concept

Informed consent for antibiotic prescription

Central ethical message here…

Page 33: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics

Beneficence

Maximizing benefits while minimizing risks

New concept

Only use antibiotics after careful consideration

the risks and the benefits

…in a fully immunized immune-competent child, antibiotics for an URTI/mild OM is NOT

needed…

Central ethical message here…

Page 34: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics

Justice

Ensure reasonable, non-exploitative and

well-considered management choices in

every patient

Central ethical message here…

Page 35: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics
Page 36: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics
Page 37: ETHICS IN THE ERA OF SUPERBUGS… · 2016. 4. 18. · Beneficence 3. Justice 4. Non-maleficence ... APUA Clinical Newsletter Vol.30 No.1 . Half of the world’s production of antibiotics

Recommended